Pfizer to discontinue twice-daily version of weight loss pill
17 giờ trước — Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, ...
12 giờ trước — Pfizer said on Friday it would not advance a twice-daily version of oral weight-loss drug danuglipron into late-stage studies after most ...
11 giờ trước — Pfizer announced Friday that it is discontinuing development of its twice-daily weight loss pill danuglipron after a clinical trial showed ...
14 giờ trước — Pfizer announced Friday it won't move forward with trials for a twice-daily regimen of its weight-loss pill intended to compete with Ozempic ...
2:50
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects ... CNBC's Angelica Peebles joins 'Squawk Box' with ...
CNBC · 15 giờ trước
12 giờ trước — Pfizer's decision to discontinue twice-daily danuglipron in obesity is probably tolerability-related, though efficacy-wise, it only seems on par ...
2:51
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects. 6.2K views · 15 hours ago ...more. CNBC ...
YouTube · CNBC Television · 15 giờ trước
CNBC's Angelica Peebles reports on the latest news from Pfizer.
CNBC · 12 giờ trước
7 giờ trước — Pfizer wants a piece of the booming obesity drug market, but it has decided to stop developing a twice-a-day pill due to adverse side ...
15 giờ trước — Pfizer is abandoning its plans for a weight loss pill to be taken twice a day after trials showed it caused significant side effects, in a ...
Nội dung tìm kiếm khác
14 giờ trước — More than half of patients in a mid-stage study had to stop taking twice-daily danuglipron due to nausea and vomiting, according to a statement ...
7 giờ trước — Pfizer (PFE) said Friday it would not advance development of a twice-daily oral weight-loss drug because of its side effects.
1:33
Pfizer (PFE) has announced that it will discontinue the development of the twice-daily version of its weight loss pill after users reported ...
Yahoo Finance · Nicholas Jacobino · 12 giờ trước
15 giờ trước — Pfizer said on Friday (Dec 1) it would not advance a twice-daily version of oral weight-loss drug Danuglipron into late-stage studies after ...
16 giờ trước — Pfizer announces positive phase 2b results for weight-loss pill danuglipron in adults with obesity, but side effects prompt focus on ...
15 giờ trước — said on Friday it would not advance a twice-daily version of oral weight-loss drug danuglipron into late-stage studies after most patients ...
12 giờ trước — By comparison, obese patients without diabetes lost about 18% of their weight compared to a placebo when taking taking Eli Lilly's Zepbound in ...
No comments:
Post a Comment